The Trump Administration’s interest in lowering drug prices, in part by making it possible for pharma companies to sell direct to consumers, sparked an engaging exchange between Debunked Podcast hosts MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. They discussed how the math would work, which pharma companies have already begun taking a direct-to-consumer approach for certain drugs, and where this would lead. Arkansas , home to Walmart, offered a preview of how this debate is playing out among states. The Natural State has banned PBMs from owning or operating retail pharmacies, and other states are considering similar actions.

“I like what Trump is trying to do here. In theory this makes sense,” Samir observed. “But if we elim

See Full Page